The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity
Abstract
Melanoma progression is generally associated with increased transcriptional activity mediated by the Yes‐associated protein (YAP). Mechanical signals from the extracellular matrix are sensed by YAP, which then activates the expression of proliferative genes, promoting melanoma progression and drug resistance. Which extracellular signals induce mechanotransduction, and how this is mediated, is not completely understood. Here, using secretome analyses, we reveal the extracellular accumulation of amyloidogenic proteins, i.e. premelanosome protein (PMEL), in metastatic melanoma, together with proteins that assist amyloid maturation into fibrils. We also confirm the accumulation of amyloid‐like aggregates, similar to those detected in Alzheimer disease, in metastatic cell lines, as well as in human melanoma biopsies. Mechanistically, beta‐secretase 2 (BACE2) regulates the maturation of these aggregates, which in turn induce YAP activity. We also demonstrate that recombinant PMEL fibrils are sufficient to induce mechanotransduction, triggering YAP signaling. Finally, we demonstrate that BACE inhibition affects cell proliferation and increases drug sensitivity, highlighting the importance of amyloids for melanoma survival, and the use of beta‐secretase inhibitors as potential therapeutic approach for metastatic melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BACE2 regulates signalling pathways including Yap, STAT3, NF-κB, and Ca2+ influx, rather than performing its classical cleavage enzyme function, in these studies.
“BACE2 regulates signalling pathways including Yap (Matafora et al., 2020), STAT3 (Chen et al., 2021b), NF-κB (Wang et al., 2020), and Ca2+ influx (He et al., 2021), rather than performing its classical cleavage enzyme function, in these studies”
From ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism (2025) · cites this paper as Matafora et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
Hoek, K. S., Eichhoff, O. M., Schlegel, N. C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., & Dummer, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2491 · Cited by 743
Lampi, M. C., & Reinhart-King, C. A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao0475 · Cited by 551
Offline Persistence of Memory-Related Cerebral Activity during Active Wakefulness
Peigneux, P., Orban, P., Balteau, E., Degueldre, C., Luxen, A., Laureys, S., & Maquet, P. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040100 · Cited by 263
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells
Rochin, L., Hurbain, I., Serneels, L., Fort, C., Watt, B., Leblanc, P., Marks, M. S., De Strooper, B., Raposo, G., & van Niel, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220748110 · Cited by 186
Carlo, A.-S., Gustafsen, C., Mastrobuoni, G., Nielsen, M. S., Burgert, T., Hartl, D., Rohe, M., Nykjaer, A., Herz, J., Heeren, J., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2425-12.2013 · Cited by 117
Common germline variants of the human APOE gene modulate melanoma progression and survival
Ostendorf, B. N., Bilanovic, J., Adaku, N., Tafreshian, K. N., Tavora, B., Vaughan, R. D., & Tavazoie, S. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0879-3 · Cited by 108
Flagged first, then by citations
Research works printed but not linked: 49
- Abildayeva K, Jansen PJ, Hirsch‐Reinshagen V, Bloks VW, Bakker AH, Ramaekers FC, De Vente J, Groen AK, Wellington CL, Kuipers F (2006) 24 (S)‐hydroxycholesterol participates in a liver X receptor‐controlled pathway in astrocytes that regulates apolipoprotein E‐mediated cholesterol efflux. J Biol Chem 281: 12799–12808 · DOI · Paper page
- Bissig C, Rochin L, van Niel G (2016) PMEL amyloid fibril formation: the bright steps of pigmentation. Int J Mol Sci 17: 1438 · DOI
- Blanco MA, LeRoy G, Khan Z, Alečković M, Zee BM, Garcia BA, Kang Y (2012) Global secretome analysis identifies novel mediators of bone metastasis. Cell Res 22: 1339 · DOI
- Chakraborty S, Njah K, Pobbati AV, Lim YB, Raju A, Lakshmanan M, Tergaonkar V, Lim CT, Hong W (2017) Agrin as a mechanotransduction signal regulating YAP through the Hippo pathway. Cell Rep 18: 2464–2479 · DOI
- Cotman SL, Halfter W, Cole GJ (2000) Agrin binds to β‐amyloid (Aβ), accelerates Aβ fibril formation, and is localized to Aβ deposits in Alzheimer's disease brain. Mol Cell Neurosci 15: 183–198 · DOI
- Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10: 1794–1805 · DOI
- Danish Rizvi SM, Hussain T, Subaiea GM, Shakil S, Ahmad A (2018) Therapeutic targeting of amyloid precursor protein and its processing enzymes for breast cancer treatment. Curr Protein Pept Sci 19: 841–849 · DOI
- Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S (2011) Role of YAP/TAZ in mechanotransduction. Nature 474: 179 · DOI · Paper page
- Fitzpatrick AW, Park ST, Zewail AH (2013) Exceptional rigidity and biomechanics of amyloid revealed by 4D electron microscopy. Proc Natl Acad Sci 110: 10976–10981 · DOI
- Frey K, Fiechter M, Schwager K, Belloni B, Barysch MJ, Neri D, Dummer R (2011) Different patterns of fibronectin and tenascin‐C splice variants expression in primary and metastatic melanoma lesions. Exp Dermatol 20: 685–688 · DOI
- Ghosh AK, Brindisi M, Yen YC, Lendy EK, Kovela S, Cardenas EL, Reddy BS, Rao KV, Downs D, Huang X et al (2019) Highly selective and potent human beta‐secretase 2 (BACE2) inhibitors against type 2 diabetes: design, synthesis, X‐ray structure and structure‐activity relationship studies. ChemMedChem 14: 545–560 · DOI
- Griffiths WJ, Crick PJ, Wang Y, Ogundare M, Tuschl K, Morris AA, Bigger BW, Clayton PT, Wang Y (2013) Analytical strategies for characterization of oxysterol lipidomes: liver X receptor ligands in plasma. Free Radic Biol Med 59: 69–84 · DOI
- Gunn AP, Masters CL, Cherny RA (2010) Pyroglutamate‐Aβ: role in the natural history of Alzheimer's disease. Int J Biochem Cell Biol 42: 1915–1918 · DOI
- Guy GP Jr, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC (2015) Vital signs: melanoma incidence and mortality trends and projections—United States, 1982–2030. MMWR Morb Mortal Wkly Rep 64: 591
- Hirata E, Girotti MR, Viros A, Hooper S, Spencer‐Dene B, Matsuda M, Larkin J, Marais R, Sahai E (2015) Intravital imaging reveals how BRAF inhibition generates drug‐tolerant microenvironments with high integrin β1/FAK signaling. Cancer Cell 27: 574–588 · DOI · Paper page
- Holle AW, Young JL, Spatz JP (2016) In vitro cancer cell–ECM interactions inform in vivo cancer treatment. Adv Drug Deliv Rev 97: 270–279 · DOI
- Johansson CH, Azimi A, Stolt MF, Shojaee S, Wiberg H, Grafström E, Hansson J, Brage SE (2013) Association of MITF and other melanosome‐related proteins with chemoresistance in melanoma tumors and cell lines. Melanoma Res 23: 360–365 · DOI
- Johnson R, Halder G (2014) The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discovery 13: 63 · DOI
- Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA (2005) VEGFR1‐positive haematopoietic bone marrow progenitors initiate the pre‐metastatic niche. Nature 438: 820 · DOI · Paper page
- Karagiannis GS, Pavlou MP, Diamandis EP (2010) Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol Oncol 4: 496–510 · DOI
- Kim MH, Kim J, Hong H, Lee SH, Lee JK, Jung E, Kim J (2016) Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation. EMBO J 35: 462–478 · DOI
- Kirkpatrick SJ, Wang RK, Duncan DD, Kulesz‐Martin M, Lee K (2006) Imaging the mechanical stiffness of skin lesions by in vivo acousto‐optical elastography. Opt Express 14: 9770–9779 · DOI
- Kleffman K, Levinson G, Wong E, Galán‐Echevarría F, Von‐Itter R, Rose I, Blumenberg L, Floristán A, Tranos J, Argibay D et al (2019) Melanoma‐secreted amyloid beta suppresses neuroinflammation and promotes brain metastasis. BioRxiv https://doi.org/10.1101/854885 [PREPRINT] · DOI
- Lamar JM, Stern P, Liu H, Schindler JW, Jiang Z‐G, Hynes RO (2012) The Hippo pathway target, YAP, promotes metastasis through its TEAD‐interaction domain. Proc Natl Acad Sci 109: E2441–E2450 · DOI
- Lee CI, Chen LE, Elmore JG (2017) Risk‐based breast cancer screening: implications of breast density. Med Clin North Am 101: 725–741 · DOI
- Liberato T, Pessotti DS, Fukushima I, Kitano ES, Serrano SM, Zelanis A (2018) Signatures of protein expression revealed by secretome analyses of cancer associated fibroblasts and melanoma cell lines. J Proteomics 174: 1–8 · DOI
- Matafora V, D'Amato A, Mori S, Blasi F, Bachi A (2009) Proteomics analysis of nucleolar SUMO‐1 target proteins upon proteasome inhibition. Mol Cell Proteomics 8: 2243–2255 · DOI
- Matafora V, Cuccurullo M, Beneduci A, Petrazzuolo O, Simeone A, Anastasio P, Mignani R, Feriozzi S, Pisani A, Comotti C (2015) Early markers of Fabry disease revealed by proteomics. Mol BioSyst 11: 1543–1551 · DOI
- Matafora V, Corno A, Ciliberto A, Bachi A (2017) Missing value monitoring enhances the robustness in proteomics quantitation. J Proteome Res 16: 1719–1727 · DOI
- Miskolczi Z, Smith MP, Rowling EJ, Ferguson J, Barriuso J, Wellbrock C (2018) Collagen abundance controls melanoma phenotypes through lineage‐specific microenvironment sensing. Oncogene 37: 3166–3182 · DOI
- Morawski M, Schilling S, Kreuzberger M, Waniek A, Jäger C, Koch B, Cynis H, Kehlen A, Arendt T, Hartlage‐Rübsamen M (2014) Glutaminyl cyclase in human cortex: correlation with (pGlu)‐amyloid‐β load and cognitive decline in Alzheimer's disease. J Alzheimers Dis 39: 385–400 · DOI
- Nallet‐Staub F, Marsaud V, Li L, Gilbert C, Dodier S, Bataille V, Sudol M, Herlyn M, Mauviel A (2014) Pro‐invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma. J Invest Dermatol 134: 123–132 · DOI
- Neumann U, Rueeger H, Machauer R, Veenstra SJ, Lueoend RM, Tintelnot‐Blomley M, Laue G, Beltz K, Vogg B, Schmid P (2015) A novel BACE inhibitor NB‐360 shows a superior pharmacological profile and robust reduction of amyloid‐β and neuroinflammation in APP transgenic mice. Mol Neurodegener 10: 44 · DOI · Paper page
- Oku Y, Nishiya N, Shito T, Yamamoto R, Yamamoto Y, Oyama C, Uehara Y (2015) Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers. FEBS Open Bio 5: 542–549 · DOI
- Ortiz A, Gui J, Zahedi F, Yu P, Cho C, Bhattacharya S, Carbone CJ, Yu Q, Katlinski KV, Katlinskaya YV (2019) An interferon‐driven oxysterol‐based defense against tumor‐derived extracellular vesicles. Cancer Cell 35: 33–45 · DOI
- Pasquali S, Hadjinicolaou AV, Chiarion Sileni V, Rossi CR, Mocellin S (2018) Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst Rev 2: CD011123
- Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15: 1243–1253 · DOI
- Sarna M, Zadlo A, Hermanowicz P, Madeja Z, Burda K, Sarna T (2014) Cell elasticity is an important indicator of the metastatic phenotype of melanoma cells. Exp Dermatol 23: 813–818 · DOI
- Shain AH, Bastian BC (2016) From melanocytes to melanomas. nature reviews. Cancer 16: 345
- Shimshek DR, Jacobson LH, Kolly C, Zamurovic N, Balavenkatraman KK, Morawiec L, Kreutzer R, Schelle J, Jucker M, Bertschi B (2016) Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice. Sci Rep 6: 21917 · DOI
- Soncini M, Corna G, Moresco M, Coltella N, Restuccia U, Maggioni D, Raccosta L, Lin C‐Y, Invernizzi F, Crocchiolo R (2016) 24‐Hydroxycholesterol participates in pancreatic neuroendocrine tumor development. Proc Natl Acad Sci 113: E6219–E6227 · DOI
- Van Niel G, Bergam P, Di Cicco A, Hurbain I, Cicero AL, Dingli F, Palmulli R, Fort C, Potier MC, Schurgers LJ (2015) Apolipoprotein E regulates amyloid formation within endosomes of pigment cells. Cell Rep 13: 43–51 · DOI
- Wang JJ, Li ZF, Li XJ, Han Z, Zhang L, Liu ZJ (2017a) Effects of microRNA‐136 on melanoma cell proliferation, apoptosis, and epithelial‐mesenchymal transition by targetting PMEL through the Wnt signaling pathway. Biosci Rep 37: 5
- Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, Gong Z, Zhang S, Zhou J, Cao K (2017b) Role of tumor microenvironment in tumorigenesis. J Cancer 8: 761 · DOI · Paper page
- Weder G, Hendriks‐Balk MC, Smajda R, Rimoldi D, Liley M, Heinzelmann H, Meister A, Mariotti A (2014) Increased plasticity of the stiffness of melanoma cells correlates with their acquisition of metastatic properties. Nanomedicine 10: 141–148 · DOI
- Westermark GT, Krogvold L, Dahl‐Jorgensen K, Ludvigsson J (2017) Islet amyloid in recent‐onset type 1 diabetes‐the DiViD study. Upsala J Med Sci 122: 201–203 · DOI
- Xu J, Reumers J, Couceiro JR, De Smet F, Gallardo R, Rudyak S, Cornelis A, Rozenski J, Zwolinska A, Marine J‐C (2011) Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat Chem Biol 7: 285 · DOI · Paper page
- Yu H, Mouw JK, Weaver VM (2011) Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol 21: 47–56 · DOI
- Zbytek B, Carlson JA, Granese J, Ross J, Mihm M, Slominski A (2008) Current concepts of metastasis in melanoma. Expert Rev Dermatol 3: 569–585 · DOI
Cited by
Sorted by citations
Li, Z., Fan, K., Suo, C., Gu, X., Zhu, C., Wei, H., Chen, L., Gao, P., & Sun, L. (2025) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaf001 · Cited by 13
Metadata
- Authors
- Matafora, V., Farris, F., Restuccia, U., Tamburri, S., Martano, G., Bernardelli, C., Sofia, A., Pisati, F., Casagrande, F., Lazzari, L., Marsoni, S., Bonoldi, E., & Bachi, A.
- Venue
- The EMBO Reports
- Published
- 2020-08-04
- Volume
- 21
- Issue
- 9
- ISSN
- 1469-221X
- 1469-3178
- PMC
- PMC7507035
- Cited by
- 44
- References
- 6
- Language
- en
- Funders
- Associazione Italiana per la Ricerca sul Cancro (IG 18607, IG 14578)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review